Andrea Tan
Stock Analyst at Goldman Sachs
(1.00)
# 3,825
Out of 4,981 analysts
46
Total ratings
38.89%
Success rate
-10.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $114 → $142 | $145.93 | -2.69% | 11 | Aug 13, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $16 → $8 | $2.27 | +252.42% | 7 | May 12, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $46 → $51 | $49.36 | +3.32% | 4 | May 5, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $39 → $27 | $7.12 | +279.21% | 6 | Mar 25, 2025 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $6.76 | -11.24% | 5 | Jul 1, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Neutral | $31 | $29.72 | +4.31% | 1 | Jun 5, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $1.59 | +25.79% | 3 | Jun 5, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $9.25 | -78.38% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $143.68 | +11.36% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $4.47 | +436.91% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $0.96 | +315.33% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $432.27 | -13.25% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6 → $4 | $1.74 | +129.89% | 2 | May 24, 2022 |
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $114 → $142
Current: $145.93
Upside: -2.69%
Iovance Biotherapeutics
May 12, 2025
Maintains: Buy
Price Target: $16 → $8
Current: $2.27
Upside: +252.42%
Tarsus Pharmaceuticals
May 5, 2025
Maintains: Neutral
Price Target: $46 → $51
Current: $49.36
Upside: +3.32%
Day One Biopharmaceuticals
Mar 25, 2025
Maintains: Buy
Price Target: $39 → $27
Current: $7.12
Upside: +279.21%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $6.76
Upside: -11.24%
Arrowhead Pharmaceuticals
Jun 5, 2024
Initiates: Neutral
Price Target: $31
Current: $29.72
Upside: +4.31%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $1.59
Upside: +25.79%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $9.25
Upside: -78.38%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $143.68
Upside: +11.36%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $4.47
Upside: +436.91%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $0.96
Upside: +315.33%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $432.27
Upside: -13.25%
May 24, 2022
Maintains: Neutral
Price Target: $6 → $4
Current: $1.74
Upside: +129.89%